Brief: Revolution Medicines, Inc. Announces Proposed Offerings Of Common Stock And Convertible Senior Notes
13/04/2026 21:54
April 13 (Reuters) - Revolution Medicines Inc RVMD.O: REVOLUTION MEDICINES, INC. ANNOUNCES PROPOSED OFFERINGS OF COMMON STOCK AND CONVERTIBLE SENIOR NOTES REVOLUTION MEDICINES INC - TO OFFER $750 MILLION COMMON STOCK AND $250 MILLION CONVERTIBLE SENIOR NOTES DUE 2033 Source text: ID:nGNX6ltd6L Further company coverage: RVMD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Revolution Medicines
See all newsAnalysis: Revolution Medicines' Europe efforts signal solo launch ambitions for cancer drug
Brief: CHMP Recommends Granting Marketing Authorisation For Rasonque For Metastatic Pancreatic Cancer In EU
Revolution Medicines wins EU committee backing for pancreatic cancer treatment (updated)
EMA recommends approval of Revolution's pancreatic cancer drug
Revolution Medicines falls on pancreatic cancer drug data concerns